Related Experiment Video
Updated: Jun 20, 2026
15:17
Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
Published on: September 25, 2011
New agents for colorectal cancer
1Division of Hematology and Oncology/Department of Medicine, Feinberg School of Medicine, Northwestern University Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois 60611, USA. m-mulcahy@northwestern.edu
Journal of the National Comprehensive Cancer Network : JNCCN
|September 22, 2009
Summary
Recent advancements in colorectal cancer (CRC) treatment include new chemotherapy agents and targeted therapies. Research focuses on novel combinations and oral agents to improve patient survival and convenience.
Area of Science:
- Oncology
- Medical Chemistry
Background:
- Colorectal cancer (CRC) treatment has evolved significantly over the past five years.
- Chemotherapy agents have shown improved survival rates for advanced CRC patients.
Purpose of the Study:
- To summarize recent developments in colorectal cancer (CRC) treatment strategies.
- To highlight the focus on novel drug combinations, oral agents, targeted therapies, immunotherapy, and vaccine therapy.
Main Methods:
- Review of recent clinical studies and research in CRC treatment.
- Analysis of new chemotherapy agents, combination regimens, and targeted drug development.
- Exploration of immunotherapy and vaccine therapy approaches.
Main Results:
- New chemotherapy agents have improved survival in advanced CRC.
- Combination therapies, including oral agents, are being investigated for prolonged survival in later lines of treatment.
- Targeted drugs, immunotherapy, and vaccines show promise in CRC treatment.
Conclusions:
- Ongoing research focuses on optimizing the use of available and novel agents and approaches for CRC.
- These advancements are expected to continue improving treatment outcomes for colorectal cancer patients.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...